Preface; Foreword; SECTION I: Current pharmacological approaches in dementia; 1. Cholinesterase inhibitors: synthesis of meta-analysis / randomised controlled trials, CW Ritchie; 2. Cholinesterase inhibitors: long-term studies, R Bullock; 3. Cholinesterase inhibitors: head-to-head studies, R Jones; 4. Ginkgo biloba, RW McCarney, J Warner; 5. Memantine, DW Wilkinson; 6. Anti-oxidants (vitamin E, n-acetyl-cysteine), M Sano; 7. Pharmacoeconomic studies, C Green; SECTION II: Biological developments and future therapies; 8. Disease modifying therapeutic strategies for Alzheimer's disease: targeting the APP/A-beta pathway, CL Masters; 9. Anti-inflammatory drugs, M Woodward; 10. Nicotine and A-beta, A Nordberg; 11. Butyl-cholinesterase, MR Farlow; 12. Sex hormones in the treatment of Alzheimer's disease, D Ames, K Draper; 13. Allosteric potentiating ligands, A Maelicke; 14. The utility of biomarkers in the diagnosis and monitoring of Alzheimer's disease, CW Ritchie; SECTION III: Management of non-cognitive issues in dementia; 15. Non-pharmacological intervention for BPSD, J Cohen-Mansfield; 16. Pharmacological intervention for BPSD, A Shah; 17. Management of affective disorders in dementia, A Thomas; 18. Management of vascular and other risks, R Stewart; 19. Social management of dementia for patient and carer, H Brodaty; SECTION IV: Treatment of non-Alzheimer's disease cognitive impairment; 20. Vascular dementia, T Erkinjuntti; 21. Frontotemporal dementia, M Ikeda; 22. Diffuse Lewy body disease and Parkinson's disease with dementia, R Barber; 23. Mild cognitive impairment (MCI), YE Geda; 24. Delirium, E Sampson; List of abbreviations; Index.